<a href=/RCL/BAN/009/?lnk=yes target=_blank><img src=/RCL/BAN/009/141014_1.gif width=1050 height=60 border=0></a>
Subscription and demo access


 
About Interfax
Press Releases
Products & Services
Contact Us
Customer Login
 


Headlines
 

10/21 17:28   Belarus PM: Ruble should be used more broadly in mutual settlements
 
10/21 17:27   Pierburg Pump Technology to launch auto part production in Pskov
 
10/21 17:27   Ukraine wants to enlarge OSCE monitoring team in Donbas - Poroshenko
 
10/21 17:25   Russia banning shipments of plant products from Ukraine starting Oct 22 (Part 2)
 
10/21 17:22   Moody's places MTS Bank ratings on review for downgrade
 
10/21 17:22   Poroshenko announces new attempt to declare artillery silence in southeastern Ukraine
 
10/21 17:18   Ukraine wants to enlarge OSCE monitoring team in Donbas - Poroshenko
 
10/21 17:18   Ukraine denies use of cluster bombs in Donbas
 
10/21 17:16   Ukraine denies use of cluster bombs in Donbas
 
10/21 17:13   Ukraine denies use of cluster bombs in Donbas
 




 

Interfax.com  |  Interfax news  |  Pharmstandard, Millhouse close deal to acquire...


News headlines


July 25, 2014 09:25

Pharmstandard, Millhouse close deal to acquire stakes in Biocad Holding

MOSCOW. July 25 (Interfax) - Pharmstandard (MOEX: PHST), a major Russian drug maker, and Millhouse have completed individual acquisitions of shares in Biocad Holding Ltd., the principal shareholder of St. Petersburg-based biotech company CJSC Biocad, the companies said in a joint statement.

Pharmstandard acquired a 20% stake in Biocad Holding Ltd., while a company affiliated with Millhouse acquired 50%.

Pharmstandard financed the acquisition with its own money, the press release states.

Biocad CEO and founder Dmitry Morozov will retain a 30% stake in Biocad Holding Ltd and will continue to run the company with his management team, the statement said.

Biocad develops, manufactures and promotes its own and generic drugs to treat illnesses in the areas of urology, gynecology, dermatovenereology, oncology and hematology, as well as autoimmune and infectious diseases. The company has a line of 14 drugs.

"Millhouse and Pharmstandard have a successful track record of working together to develop leaders in the pharmaceutical market. The companies previously cooperated on the acquisitions of ICN Pharmaceuticals, Inc. and CJSC Masterlek, and on Pharmstandard's initial public offering," the press release said.

It was reported earlier that in this deal the companies would buy the stake of Gazprombank (MOEX: GZPR), which acquired a controlling stake in the pharmaceutical company in 2011 for about $250 million-$300 million, as well as part of the stake held by company management.

RMG senior analyst Ksenia Arutyunova valued all of Biocad at $1 billion. Therefore, the stakes acquired by Pharmstandard and Millhouse are worth $200 million and $500 million respectively.

Millhouse is acting as a financial investor, who will divest the stake at some point, Arutyunova said, adding that this stake could be bought by Pharmstandard.

Biocad currently sells its products in Russia and other CIS countries. The company has offices in Ukraine, Belarus, Brazil, China, India and the United States. Biocad is also setting up production of drugs based on monoclonal antibodies in Brazil.

Biocad has two factories in Russia - in the Moscow Region and in the St. Petersburg special economic zone. The company had revenue of 3 billion rubles in 2013.

It was reported earlier that U.S. drug makers Pfizer and Amgen were interested in buying Biocad. The company was valued at $0.75 billion-$1 billion.

Vp of

(Our editorial staff can be reached at eng.editors@interfax.ru)

/Interfax/
 Subscription
You can access a demo version of, receive more information about or subscribe to Interfax publications by filling in and returning the form below. We also have dozens of reports in the Russian language, please indicate if you are interested.
Title:


Phone:


E-mail:


First name:


Company:


Country:
Last name:


Division:


City:
Products:
Central Asia & Caucasus Business Weekly
Central Asia General Newswire
Global Gas Analytics
Global Natural Gas Daily
Interfax Via Bloomberg Terminal
Kazakhstan General Newswire
Kazakhstan Mining Weekly
Kazakhstan Oil & Gas Weekly
Russia & CIS Announcements
Russia & CIS Banking and Finance Weekly
Russia & CIS Business and Financial Daily
Russia & CIS Business and Financial Newswire
Russia & CIS Business and Investment Weekly
Russia & CIS Business Law Weekly
Russia & CIS Business news
Russia & CIS Defense Industry Weekly
Russia & CIS Diplomatic Panorama
Russia & CIS Energy Daily
Russia & CIS Energy Newswire
Russia & CIS Events Calendar
Russia & CIS Food and Agriculture Weekly
Russia & CIS General Newswire
Russia & CIS Headline News
Russia & CIS Insurance Weekly
Russia & CIS IT and Telecom Weekly
Russia & CIS Metals and Mining Weekly
Russia & CIS Military Daily
Russia & CIS Military Newswire
Russia & CIS Military Weekly
Russia & CIS Oil and Gas Weekly
Russia & CIS Presidential Bulletin
Russia & CIS Statistics Weekly
Russia Health & Pharmaceuticals
Russia Market Roundup
Russia Press Review
Ukraine Business Daily
Ukraine Business Weekly
Ukraine General Newswire

October 21, 2014
 
17:18
 
17:18
Ukraine denies use of cluster bombs in Donbas
 
17:16
Ukraine denies use of cluster bombs in Donbas
 
17:13
Ukraine denies use of cluster bombs in Donbas
 
17:10
Tranche from EU macro-finance aid could arrive in Ukraine in November - Kyiv
 
17:08
Ukraine denies use of cluster bombs in Donbas
 
17:07
Estonian ports handle 1% more cargo in 9M
 
17:01
Gov't preparing bill allowing Central Bank to use 15% of its profit on raising banks' capital (Part 2)
 
17:00
MICEX and RTS Indexes at 17:00 MSK
 
17:00
Russian Geographical Society's projects unaffected by sanctions - president
 
16:59
 
16:57
DPR gets humanitarian aid from Egypt
 
16:57
Snow machine operator with which Falcon collided not drinker, has heart problem - lawyer (Part 3)
 
16:52
IES to reorganize generating assets, close ineffective power plants
 
 more headlines 



Interviews
 

.
Pakistani Ambassador to Russian Zaheer Aslam Janjua has given an interview to Interfax in which he speaks about prospects for supplying more Pakistani food products to Russia, the quality of such products and invites Russian companies to implement infrastructural projects in Pakistan.

more
.
.
John Padilla, managing director of consultants IPD Latin America, talks to Interfax about Colombia’s investment climate.

more
.
.
Palestinian leader Mahmoud Abbas signals readiness for compromise and praises Russia’s role in settling conflict in Middle East in an exclusive interview with Interfax

more

 
  
 ©   1991—2014   Interfax Information Service. All rights reserved.
contact information   |   Interfax offices   |   made by web.finmarket

News and other data on this site are provided for information purposes only, and are not intended for republication or redistribution. Republication or redistribution of Interfax content, including by framing or similar means, is expressly prohibited without the prior written consent of Interfax.

Browse other Interfax sites:  Interfax.ru   |   IFX.RU   |   Interfax Group   Rambler's Top100